Fifth Third Bancorp
- SEC CIK
- 0000035527
- Latest filing
- Aug 5, 2026
ENTA holding history
Enanta Pharmaceuticals Inc in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings
- Shares (Q2 2026)
- 367
- Value
- $5.35K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 367 | $5.35K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 367 | $4.63K | <0.1% | +367 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −111−100.0% | Sold out | Holders |
| Q2 2025 | 111 | $839 | <0.1% | +111 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −358−100.0% | Sold out | Holders |
| Q3 2023 | 358 | $4.00K | <0.1% | +339+1,784.2% | Added | Holders |
| Q2 2023 | 19 | $407 | <0.1% | −25−56.8% | Reduced | Holders |
| Q1 2023 | 44 | $1.78K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 44 | $2.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 44 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 44 | $2.00K | <0.1% | −18−29.0% | Reduced | Holders |
| Q1 2022 | 62 | $4.00K | <0.1% | −2−3.1% | Reduced | Holders |
| Q4 2021 | 64 | $5.00K | <0.1% | +45+236.8% | Added | Holders |
| Q3 2021 | 19 | $1.00K | <0.1% | +19 | New | Holders |